哈三联 (002900.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−21.6x

Market Cap

CNY 4.48B

MomentumView details →

1D Return

+2.76%

YTD Return

−1.77%

RSI (14)

43.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−21.6x

Market Cap

CNY 4.48B

RSI (14)

43.5

MomentumView details →

1D Return

+2.76%

YTD Return

−1.77%

ProfitabilityView details →

Gross Margin

37.15%

Net Margin

−39.08%

EBITDA Margin

−25.37%

ROE (TTM)

−18.00%

ROA (TTM)

−9.54%

Asset Turnover

0.24x

GrowthView details →

Revenue YoY

−25.44%

EPS YoY

—

FCF YoY

−57.33%

Revenue CAGR 3Y

−8.44%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.55x

Current Ratio

0.88x

Quick Ratio

0.65x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

813.23M

Net Income (TTM)

−317.84M

Op. CF (TTM)

−106.34M

Latest newsMore news →

Chinese innovative drug and CXO stocks rebounded strongly, with the CSI Innovative Drug Industry Index rising 28.04% since June 9, 2026, and several stocks hitting daily limits on August 7, 2026.28d ago

Similar companies

三变科技002112.SZ *ST利源002501.SZ 艾比森300389.SZ 瑞丰高材300243.SZ 好想你002582.SZ 劲仔食品003000.SZ Find similar companies →

Latest newsMore news →

Chinese innovative drug and CXO stocks rebounded strongly, with the CSI Innovative Drug Industry Index rising 28.04% since June 9, 2026, and several stocks hitting daily limits on August 7, 2026.28d ago